about
Hepatitis C genotype 4: The past, present, and futurePreoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia.Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia.Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?Serum complement C4a and its relation to liver fibrosis in children with chronic hepatitis C.Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian childrenA novel immunoregulatory protein in human colostrum, syntenin-1, for promoting the development of IgA-producing cells from cord blood B cells.Serum cystatin C correlates negatively with viral load in treatment-naïve children with chronic hepatitis C.Diagnostic value of hepatic intercellular adhesion molecule-1 expression in Egyptian infants with biliary atresia and other forms of neonatal cholestasis.Significant hepatic expression of IL-2 and IL-8 in biliary atresia compared with other neonatal cholestatic disorders.Differential hepatic expression of CD56 can discriminate biliary atresia from other neonatal cholestatic disorders.Design and validation of a diagnostic score for biliary atresia.Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia.Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants.Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasisNovel mutations in a Japanese patient with CD19 deficiencyValue of hepatic subcapsular flow by color Doppler ultrasonography in the diagnosis of biliary atresia
P50
Q26775815-89A38DF6-09A9-409E-9C95-03A5417C6F5FQ33735487-D9CAB41A-5DAA-4BF9-B0D7-B8A9771C6624Q34256849-C46C5BC8-5355-43F2-B0A2-0FF88BE6A3A5Q36815034-1550322C-53ED-4F46-ABC3-5B37CDB512CAQ37157863-AA2384D1-341A-4EA0-9E3E-617B6356A3FEQ37477801-3AB4F2E7-8F3C-424B-8F11-D3B56952B58BQ37724686-9450EE60-125A-4AE2-A25F-90A139BE445FQ39826536-DAAD16BF-AA5E-4082-9141-954A9BD4ABEEQ43042146-488C5007-3768-4F93-9ED1-995D330A5036Q46179767-ADC9F449-B1B8-429F-ABD2-FBA51591B258Q46398826-1964E1DA-66D1-4FDF-9C3C-6A528AB16FF8Q46566876-4998854B-9D6A-4C6C-A453-8B30AAAF5D76Q46571009-15D84BCB-3F8E-4B0E-9B47-298878445DEFQ46756876-D09E17A0-FD2E-4D40-96EA-42F4A525F870Q47685786-EC68A5B4-7875-4774-BDA0-8930E21A68FDQ57137893-31452043-B46E-4033-953F-14BE4EBC758FQ63804793-BAAE4632-F328-4785-9043-54E41F652057Q86171988-839F291B-B870-48A0-9E91-672718B0FB6E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mostafa Mohamed Sira
@ast
Mostafa Mohamed Sira
@en
Mostafa Mohamed Sira
@es
Mostafa Mohamed Sira
@nl
Mostafa Mohamed Sira
@sl
type
label
Mostafa Mohamed Sira
@ast
Mostafa Mohamed Sira
@en
Mostafa Mohamed Sira
@es
Mostafa Mohamed Sira
@nl
Mostafa Mohamed Sira
@sl
altLabel
Mostafa Mohamed Sira
@en
prefLabel
Mostafa Mohamed Sira
@ast
Mostafa Mohamed Sira
@en
Mostafa Mohamed Sira
@es
Mostafa Mohamed Sira
@nl
Mostafa Mohamed Sira
@sl
P106
P1153
7801557485
P2038
Mostafa_Sira2
P21
P31
P496
0000-0002-3272-0497